Chuquiure VE

Language: Spanish
References: 15
Page: 31-33
PDF size: 47.23 Kb.

ABSTRACT

At present, the use of techniques that lead to assess coronary flow is determined by methods that include mostly coronary angiography, which is a fundamental tool in the evaluation of acute myocardial infarction carrier patients. The assessment of the myocardial flow permeability state, determined through TIMI-4 flow, allows to establish more precisely the impact of the used reperfusion treatment. The most common way of assessing it at the Coronary Unit is through contrast echocardiography using pharmacological agents with harmonic properties.

REFERENCES

1. The TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) Trial. N Engl J Med 1985; 312: 932-936.

2. The Gusto Investigators: An International randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.

3. The Gusto Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1622.

4. Gibson M, Cannon C, Daley W, Dodge T, Alexander B, Marble S, et al: TIMI Frame count A quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.

5. Gibson C, Cannon C, Ryan K, Marble S, Mc Cabe C, Van er Werf F, Braunwald E: Relation ship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drug. Circulation 2000; 101: 125-30.

6. Carrilo J, Chuquiure E, Martínez C, González H, Jaureguí L, Peña M, et al: Análisis de la permeabilidad por trombólisis de la arteria responsable de infarto miocárdico agudo. Arch Inst Cardiol Mex 1997; 67: 186-194.

7. Kloner R, Rude R, Carlson N, Maroko P, DeBoer L, Braunwald E: Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which come first? Circulation 1980; 62: 945-952.

8. Lupi E, González H, Juárez U, Chuquiure E, Vieyra G, Martínez C: La meta de la reperfusión en los síndromes isquémicos coronarios agudos con elevación del segmento ST. El gran Paradigma: Lo que hay más allá del flujo TMI 3 epicárdico: El TIMI 4 miocárdico. Arch Cardiol Mex 2002; 72: 311-349.

9. Tei C, Sakamaki T, Shah P, Meerbaum S, Shimoura S, Kondo S, Corday E: Myocardial contrast echocardiography: A reproducible technique of myocardial opacification for identifying regional perfusion deficits. Circulation 1983; 67: 585-593.

10. Thomas J, Rubin D: Tissue harmonic Imaging: Why does it work? J Am Soc Echocardiogr 1998; 11: 803-808.

11. Wei K, Jayaweera A, Firozan S, Linka A, Skyba D, Kaul S: Basis for detection of stenosis using venous administration of mirobubles during myocardial contrast echocardiography bolus or continuos infusion? J Am Coll Cardiol 1998; 32: 252-60.

12. Firschke C, Lindner J, Wei K, Goodman N, Skyba D, Kaul S: Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second generation echocardiographic contrast agent. Circulation 1997; 96: 959-967.

13. Iliceto S, Marangelli V, Marchese A, Amico A, Galiuto L, Rizzon P: Myocardial contrast echocardiography in acute myocardial infarction. Eur Heart J 1996; 17: 344-353.

14. Leistad E, Ohmor K, Peterson T, Christensen G, DeMaria K: Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography. J Am Coll Cardiol 2001; 37: 624-631.

15. Santoro G, Valenti R, Buonamici P, Bolognese L, Cesirason G, Moschi G, et al: Relation between st-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 1998; 82: 932-937.